Literature DB >> 35811661

Application of Endoscopic Ultrasound Combined with Multislice Spiral CT in Diagnosis and Treatment of Patients with Gastrointestinal Eminence Lesions.

Jie Xiong1, Jie Jiang2, Ying Chen1, Ye Chen1, Chenyi Xie3, Shuchang Xu1.   

Abstract

Objective: To evaluate the application of endoscopic ultrasound (EUS) combined with multislice spiral CT (MSCT) in the diagnosis and treatment of patients with gastric eminence lesions.
Methods: A total of 160 patients with gastric eminence lesions enrolled in our hospital from June 2018 to June 2021 were included and received EUS and MSCT. The results of the two examinations and the postoperative pathological results were compared.
Results: The common pathological types of gastric eminence lesions include polyps and stromal tumors, with the most common sites of lesions in the gastric antrum, followed by the fundus of the stomach and the gastric body. Gastric eminence lesions mostly originate from the mucosal layer and muscularis mucosa, accounting for 83.13% of the total. With pathological results as the gold standard, the detection rate of MSCT was 90.63%, and that of EUS was 78.13%. With the joint diagnosis as a reference, the receiver operating curve (ROC) revealed a higher diagnostic efficiency of MSCT and EUS.
Conclusion: The accuracy of MSCT in the diagnosis of gastric eminence lesions is significantly higher than that of EUS, both of which can offer useful guidance for the choice of endoscopic treatment methods. The combination of MSCT and EUS examination before endoscopic gastroscopy may provide a better treatment efficacy on gastric protruding lesions with high safety.
Copyright © 2022 Jie Xiong et al.

Entities:  

Mesh:

Year:  2022        PMID: 35811661      PMCID: PMC9259227          DOI: 10.1155/2022/1417104

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.464


1. Introduction

Gastric eminence lesions are mostly caused by the compression of extramural organs or lesions and the large folds of the gastric mucosa [1-3]. Gastric eminence lesions are caused by the degeneration and necrosis of the vagus nerve and sympathetic nerve, resulting in abnormal secretion of various intestinal hormones and changes in the intestinal environment [4]. Currently, the diagnostic efficiency of the property and origin of the lesion by electronic gastroscopy is poor, so endoscopy and multislice spiral CT (MSCT) are frequently used in clinical practice for preoperative diagnosis to provide a guidance for subsequent treatment [5-8]. Endoscopic ultrasound (EUS), with ultrasound and endoscopy, can clearly show the digestive tract wall, adjacent organs, and tissues, which helps clarify the cause of the lesion by preliminarily determining the property of the lesion according to its echo characteristics [9-12]. MSCT can clearly show the depth, location, and size of tumor infiltration and can effectively determine the presence of lymph node metastasis in the lung, mediastinum, and distal organ tissues. EUS allows direct visualization of mucosal lesions in the gastrointestinal tract, while real-time scanning can be performed using endoscopic ultrasound, thus further improving diagnostic accuracy. To further enhance the treatment efficacy of gastric eminence lesions this study explored the application value of EUS combined with MSCT in the diagnosis of patients with gastric eminence lesions to provide a clinical reference of endoscopic treatment.

2. Research Design

2.1. Patient Screening and Grouping

A total of 160 patients with gastric eminence lesions enrolled in Tongji Hospital, Tongji University School of Medicine, from June 2018 to June 2021 were included for retrospective analysis. This study has been approved by the ethics committee of Tongji Hospital, Tongji University School of Medicine, No. 197TJ29-1.

2.2. Inclusion Criteria

Patients who were diagnosed with gastric eminence lesions after receiving electronic gastroscopy in our hospital and received endoscopic treatment after further determination of the range and property of the lesions by EUS and MSCT, with complete clinical data, and who were fully informed of the purpose and process of the study and provided written informed consent were included.

2.3. Exclusion Criteria

Patients with progressive gastric cancer; with external pressure lesions; with other serious organic diseases, coagulation dysfunction, or malignant tumors; and with cognitive impairment, communication impairment, or physical impairment were excluded.

2.4. Methods

EUS examination: the examination was carried out using an ultrasound host (model: Fuji SU-8000) + EUS (model: Fuji EG-530UT), equipped with 12, 15, and 20 MHz ultrasound probes. Small superficial lesions were inspected with the 12 MHz ultrasound microprobe. The water filling method and the water bag technique were used, and the frequency and scanning method of the ultrasound probe was switched according to the size and location of the lesion [13-16]. MSCT examination: the patients fasted for 8 hours, drank 600-1000 ml of water 20 minutes before the examination, and received 20 mg of amidoamine (Fujian Sanai Pharmaceutical Co., Ltd., Approval No. H35020158) through intramuscular injection. With the patients in a supine position according to the conditions of the gastric lesions, a plain CT scan was performed, ranging from the right side of the diaphragm to the duodenum, with a voltage of 120 KV, a current of 250-300 mA, a thickness of 5 mm, a pitch of 1.25, and reconstruction thickness of 0.625 mm [17-20]. Then, contrast CT was performed after the injection of the iopromide (Schering Pharmaceutical Co., Ltd., Approval No. H10970166) using a high-pressure syringe, with an injection speed of 3.5 ml/s. Arterial phase was scanned 30 s after injection covering the esophagus, abdomen, and whole stomach, and venous phase was scanned 60 s after the injection to observe the tissue damage adjacent to the lesion and the liver and distant metastasis. The imaging examination results of all patients were diagnosed by two radiologists and sonographers. Endoscopic treatment was performed for some eminence lesions, including high-frequency electrocoagulation resection, mucosal resection, mucosal dissection-tumorectomy, mucosal dissection-tumor excision plus titanium clip closure, and puncture sclerotherapy; some submucosal tumors were surgically removed, and pathological examination was performed. Mucosal dissection-tumor tumorectomy uses a double-port therapeutic endoscope. A snare is placed through one port to cover the mucosal tissue on the tumor surface, and high-frequency electrical resection of the surface mucosa is performed, or a needle knife is used to cut the mucosal tissue on the surface of the tumor to expose the submucosal tumor; then, a biopsy forceps is used through another hole to clamp the tumor and lift it up, and a snare is used to cover the tumor at the bottom of the tumor, to perform high-frequency electrical resection.

2.5. Postoperative Follow-Up

The patients received reexamination by gastroscopy at 3, 6, and 12 months after surgery to obtain the patient recovery data. Biopsy was performed again to determine the occurrence of local recurrence if necessary.

2.6. Statistical Analyses

The data obtained in this study were analyzed using SPSS20.0 software, and GraphPad Prism 7 (GraphPad Software, San Diego, USA) was used to plot the graphics. The counting data are expressed as n(%) and analyzed using the chi-square test. The measurement data are expressed as mean ± SD and analyzed using the t-test. The specificity and sensitivity of receiver operating curve (ROC) and the area under the curve (AUC) were calculated. Differences were considered statistically significant at P < 0.05. Sensitivity = number of true positives/(number of true positives + number of false negatives)∗100%; specificity = number of true negatives/(number of true negatives + number of false positives)∗100%. The sensitivity and specificity of this study are for the detection of gastric eminence lesions, with no subdivision of the disease.

3. Results

3.1. The Distribution of Gastric Eminence Lesions

The distribution of the lesions of 160 patients was analyzed. The diameter of gastric eminence lesions was about 1.47 ± 0.95 cm. The common pathological types of gastric eminence lesions include polyps and stromal tumors, with the most common sites of lesions in the gastric antrum, followed by the fundus of the stomach and the gastric body. The pathological types of the gastric antrum were mostly polyps, of the fundus lesions were mostly stromal tumors, of the gastric body lesions were mainly polyps on the greater curvature side, and of the gastric angle were chiefly malignant (Table 1).
Table 1

The distribution of different pathological types of gastric eminence lesions.

PolypStromal tumorMalignant lesionsLipomaAdenomaPapillomaHemangiomaCystSchwannomaLymphangiomyomaTotal
Cardia1100002000015
Fundus of stomach4350000010040
Greater curvature of the stomach533000001012
Lesser curvature of the stomach23000010006
Gastric anterior wall32001000017
Gastric posterior wall32010000006
Gastric angle00300000003
Greater curvature of gastric antrum1406110000022
Lesser curvature of gastric antrum1300000000013
Anterior wall of gastric antrum1311200000017
Posterior wall of gastric antrum1104020000017
Pylorus20000000002
Total8148174421111160

3.2. Histological Characteristics of Gastric Eminence Lesions

Gastric eminence lesions mostly originate from the mucosal layer and muscularis mucosa, accounting for 83.13% of the total (Table 2).
Table 2

Origin level of different pathological types of gastric eminence lesions.

Type of lesionMucosal layerMuscularis mucosaSubmucosaMuscularis propriaUnclear originTotal
Polyp77111281
Stromal tumor04242048
Malignant lesions0971017
Lipoma004004
Adenoma031004
Papilloma011002
Hemangioma000001
Cyst001001
Schwannoma001001
Lymphangiomyoma000101
Total77562052160

3.3. Diagnosis Results of Pathology, EUS, and MSCT

With pathological results as the gold standard, the detection rate of MSCT was 90.63%, and that of EUS was 78.13% (X2 = 9.4815, P = 0.005). The preoperative MSCT examination did not provide a clear diagnosis result for 15 patients, with gastric antrum being the most common lesion (40%) and muscularis mucosa being the most common level of lesion causes (46.67%). The preoperative EUS examination did not provide a clear diagnosis result for 35 patients, with gastric antrum being the most common lesion (40%), muscularis mucosa being the most common level of lesion causes (45.71%), and stromal tumor (25.71%) being the most frequent type of lesions (Tables 3–5).
Table 3

Diagnosis results of pathology, EUS, and MSCT.

Type of lesionPathological resultsMSCTEUSMSCT and EUS
Polyp81727081
Stromal tumor48443648
Malignant lesions17141017
Lipoma4544
Adenoma4524
Papilloma2212
Hemangioma1111
Cyst1211
Schwannoma1000
Lymphangiomyoma1000
Total160145125158
Table 4

The pathological condition of undiagnosed patients by MSCT.

Origin levelnLesion siteType of lesion
Muscularis mucosa7Antrum (3 cases)3 cases of polyps
Fundus of stomach (3 cases)3 cases of stromal tumor
Stomach body (1 case)1 case of stromal tumor

Submucosa4Antrum (3 cases)3 cases of polyps
Stomach body (1 case)1 case of gastric mucosa-associated lymphoma

Muscularis propria3Stomach body (2 cases)2 cases of lymphangiomas
Antrum (1 case)1 case of polyps

Unclear origin1Antrum (1 case)1 case of polyps
Table 5

The pathological condition of undiagnosed patients by EUS.

Origin levelnLesion siteType of lesion
Muscularis mucosa16Fundus of stomach (8 cases)8 cases of stromal tumors
Antrum (8cases)8 cases of malignant lesions

Submucosa12Antrum (7 cases)7 cases of lipoma
Fundus of stomach (4 cases)4 cases of stromal tumors
Stomach body (1 case)1 case of schwannoma

Muscularis propria5Stomach body (4 cases)2 cases of polyp, 1 case of stromal tumors, 2 cases of lymphangioma

Unclear origin2Cardia2 cases of polyps

3.4. ROC Curve Evaluates the Diagnostic Efficacy of EUS and MSCT

With the joint diagnosis as a reference, the ROC curve was formulated to compare the diagnostic efficiency: combined detection > MSCT > EUS (P < 0.05). The AUC of MSCT was 0.855 (0.850, 0.900), with a sensitivity of 0.806 and specificity of 0.807; the AUC of EUS was 0.871 (0.860, 0.963), with a sensitivity of 0.845 and specificity of 0.811; and the AUC of the combined assay was 0.900 (0.955, 0.999), with a sensitivity of 0.916 and specificity 0.914 (Figure 1).
Figure 1

ROC curve.

3.5. Treatment Results

Among the 160 patients, 83 patients (77 cases with polyps, 4 cases with stromal tumors, 1 case with malignant lesions, and 1 case with papilloma) underwent high-frequency electrocoagulation resection, and 6 patients (2 cases with polyps, 1 case with stromal tumors, 1 case with adenoma, 1 case with papilloma, and 1 case with cysts) underwent high-frequency electrocoagulation resection, with good healing of the wound 6 months after treatment and no local recurrence after 6-24 months of follow-up. Of 69 patients (2 cases with polyps, 42 cases with stromal tumors, 15 cases with malignant lesions, 4 cases with lipoma, 3 cases with adenoma, 1 case with hemangioma, 1 case with schwannoma, and 1 case with lymphangioma) who received mucosal dissection-tumorectomy, 3 cases experienced intraoperative bleeding, and 2 cases had delayed postoperative bleeding, for which hemostasis was performed successfully. Due to the large tumor body and the risk of perforation, 2 patients (1 case with stromal tumors and 1 case with malignant lesions) were transferred to surgical treatment, in which the tumors were further determined as gastric fundus stromal tumors, with a propensity for malignancy. The 2 patients were lost at postoperative follow-up (see Table 6 for details).
Table 6

Treatment methods for different pathological types of lesions.

LesionnEndoscopic minimally invasive treatment
High-frequency electrocoagulation resectionMucosal dissection-tumorectomy
Polyp81792
Stromal tumor48543
Malignant lesions17116
Lipoma404
Adenoma413
Papilloma220
Hemangioma101
Cyst110
Schwannoma101
Lymphangioma101
Total1608971

4. Discussion

In the diagnosis of gastric eminence lesions, EUS presents the shape and size of the lesion through endoscopy and clearly shows the structure of the stomach wall, from the mucosal layer to the muscularis mucosa, the submucosal layer, the muscularis propria, and the serosal layer, with hyperecho, hypoecho, hyperecho, hypoecho, and hyperecho signals, respectively. It yields high accuracy in determining the size of the lesion and the origin and range of the lesion tissue [21-24]. With pathological results as the gold standard, the detection rate of EUS was 78.13%. 35 patients had unclear EUS results, with gastric antrum being the most common lesion (40%), muscularis mucosa being the most common level of lesion causes (45.71%), and stromal tumor (25.71%) being the most frequent type of lesion, indicating a high rate of missed diagnosis of the stromal tumors, which is consistent with the research results by Ikoma et al. [25]. MSCT can realize multidirectional and multiangle observation of the lesion by using technologies such as MPR, which clearly presents the tumor size, location, shape, growth pattern, boundary, enhancement characteristics, ulcer, and calcification degree and shows the relationship between the disease and surrounding organs and lymph node metastasis, especially for stromal tumors. In the present study, the detection rate of MSCT was 90.63%, which was significantly higher than that of 78.13% for EUS. The common pathological types of gastric eminence lesions tumor include polyps and stromal tumors, with the most common sites of lesions in the gastric antrum, followed by the fundus of the stomach and the gastric body. Gastric eminence lesions mostly originate from the mucosal layer and muscularis mucosa, accounting for 83.13% of the total. With the joint diagnosis as a reference, the ROC curve revealed a higher diagnostic efficiency of MSCT versus EUS. Clinically, misdiagnosis is frequently seen in stromal tumors as hypoechoic and well-defined masses in EUS. Stromal tumors mostly occur in the fundus of the stomach, which originate in the muscle layer. The signs of MSCT for mesenchymal tumors are intracavernous growth with clear borders and uniform enhancement on enhancement scans when the tumor is small in size and irregular in shape with blurred borders and inhomogeneous enhancement on enhancement scans when the tumor is large in size. In terms of misdiagnosis in the present study, EUS mostly involved stromal tumors, while MSCT had a high diagnostic yield for stromal tumors, suggesting that MSCT plays a certain auxiliary role in distinguishing stromal tumors. The ROC revealed that in the diagnosis of gastric eminence lesions, the performance of a single ultrasound image is undesirable, while the combination of EUS and MSCT is more effective. Furthermore, the combination of clinical manifestations and pathological characteristics of the patients can prominently enhance the accuracy of the diagnosis of lesions. Among the 160 patients, 83 underwent high-frequency electrosurgery, and 6 underwent nylon thread ligation, with good healing of the wound 6 months after treatment and no local recurrence after 6-24 months of follow-up. Of 69 patients who received mucosal dissection-tumorectomy, 3 cases experienced intraoperative bleeding and 2 cases had delayed postoperative bleeding, for which hemostasis was performed successfully; 2 cases were transferred to surgical treatment. In this study, no cases of perforation were found, which may be attributed to the operation skills or the small sample size of this study, suggesting that mucosal dissection-tumorectomy is safe in the treatment of gastric eminence lesions and can enhance the treatment effect. The microultrasound of ultrasound endoscopy cannot penetrate the intrinsic muscle layer of the tumor and identify the level of lesion, and some patients have peritoneal fibrosis and inflammatory reaction, which may further thicken the esophageal wall and adversely affect the accuracy of staging diagnosis. MSCT is a cross-sectional scan, which cannot effectively distinguish esophageal cancer from the normal esophageal wall and is less effective in identifying soft tissues. Chinese medicine has accumulated a wealth of experience in the treatment of gastric eminence lesions, which can effectively relieve symptoms and enhance clinical efficacy. Gastric eminence lesions can be treated with catgut embedding acupuncture. The catgut used is an allogeneic protein, and when the allogeneic protein is buried in the acupuncture point, the body's rejection reaction to the allogeneic protein continues to stimulate the acupuncture point, thereby achieving the purpose of treating diseases, with the advantages of economic applicability, simple operation, short duration, and high efficiency.

5. Conclusion

The accuracy of MSCT in the diagnosis of gastric eminence lesions is significantly higher than that of EUS, both of which can offer useful guidance for the choice of endoscopic treatment methods. The combination of MSCT and EUS examination before endoscopic gastroscopy may provide a better treatment efficacy on gastric protruding lesions with high safety. The limitation of this study is that less follow-up study was performed in postoperative patients; therefore, this study only serves as a guide for diagnosis, and further research in the treatment is required in future studies.
  21 in total

1.  Discrepancy in diagnosis of gastric submucosal tumor among esophagogastroduodenoscopy, CT, and endoscopic ultrasonography: a retrospective analysis of 93 consecutive cases.

Authors:  Osamu Goto; Haruka Kambe; Keiko Niimi; Satoshi Mochizuki; Itsuko Asada-Hirayama; Chihiro Minatsuki; Satoshi Ono; Shinya Kodashima; Nobutake Yamamichi; Yutaka Yamaji; Mitsuhiro Fujishiro; Kazuhiko Koike
Journal:  Abdom Imaging       Date:  2012-12

2.  Evaluation of an e-learning system for diagnosis of gastric lesions using magnifying narrow-band imaging: a multicenter randomized controlled study.

Authors:  Hiroyoshi Nakanishi; Hisashi Doyama; Hideki Ishikawa; Noriya Uedo; Takuji Gotoda; Mototsugu Kato; Shigeaki Nagao; Yasuaki Nagami; Hiroyuki Aoyagi; Atsushi Imagawa; Junichi Kodaira; Shinya Mitsui; Nozomu Kobayashi; Manabu Muto; Hajime Takatori; Takashi Abe; Masahiko Tsujii; Jiro Watari; Shuhei Ishiyama; Ichiro Oda; Hiroyuki Ono; Kazuhiro Kaneko; Chizu Yokoi; Tetsuya Ueo; Kunihisa Uchita; Kenshi Matsumoto; Takashi Kanesaka; Yoshinori Morita; Shinichi Katsuki; Jun Nishikawa; Katsuhisa Inamura; Tetsu Kinjo; Katsumi Yamamoto; Daisuke Yoshimura; Hiroshi Araki; Hiroshi Kashida; Ayumu Hosokawa; Hirohito Mori; Haruhiro Yamashita; Osamu Motohashi; Kazuhiko Kobayashi; Michiaki Hirayama; Hiroyuki Kobayashi; Masaki Endo; Hiroo Yamano; Kazunari Murakami; Tomoyuki Koike; Kingo Hirasawa; Youichi Miyaoka; Hidetaka Hamamoto; Takuto Hikichi; Norihiro Hanabata; Ryo Shimoda; Shinichiro Hori; Tadashi Sato; Shinya Kodashima; Hiroyuki Okada; Tomohiko Mannami; Shojiro Yamamoto; Yasumasa Niwa; Kazuo Yashima; Satoshi Tanabe; Hiro Satoh; Fumisato Sasaki; Tetsuro Yamazato; Yoshiou Ikeda; Hogara Nishisaki; Masahiro Nakagawa; Akio Matsuda; Fumio Tamura; Hitoshi Nishiyama; Keiko Arita; Keisuke Kawasaki; Kazushige Hoppo; Masashi Oka; Shinichi Ishihara; Michita Mukasa; Hiroaki Minamino; Kenshi Yao
Journal:  Endoscopy       Date:  2017-06-21       Impact factor: 10.093

3.  Magnifying endoscopy with narrow-band imaging is useful in the differential diagnosis between low-grade adenoma and early cancer of superficial elevated gastric lesions.

Authors:  Shinichiro Maki; Kenshi Yao; Takashi Nagahama; Takahiro Beppu; Takashi Hisabe; Yasuhiro Takaki; Fumihito Hirai; Toshiyuki Matsui; Hiroshi Tanabe; Akinori Iwashita
Journal:  Gastric Cancer       Date:  2012-05-17       Impact factor: 7.370

4.  Gastric subepithelial masses: evaluation of multidetector CT (multiplanar reconstruction and virtual gastroscopy) versus endoscopic ultrasonography.

Authors:  Riza Sarper Okten; Sabite Kacar; Fahrettin Kucukay; Nurgul Sasmaz; Turhan Cumhur
Journal:  Abdom Imaging       Date:  2012-08

Review 5.  Usefulness of magnifying narrow-band imaging endoscopy for the diagnosis of gastric and colorectal lesions.

Authors:  Ichiro Hirata; Yoshihito Nakagawa; Masaaki Ohkubo; Naohisa Yahagi; Kenshi Yao
Journal:  Digestion       Date:  2012-01-19       Impact factor: 3.216

6.  Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography.

Authors:  Sung Wook Hwang; Dong Ho Lee; Sang Hyub Lee; Young Soo Park; Jin Hyeok Hwang; Jin Wook Kim; Sook Hyang Jung; Na Young Kim; Young Hoon Kim; Kyoung Ho Lee; Hyung-Ho Kim; Do Joong Park; Hye Seung Lee; Hyun Chae Jung; In Sung Song
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

7.  The learning curve for narrow-band imaging in the diagnosis of precancerous gastric lesions by using Web-based video.

Authors:  Diogo Dias-Silva; Pedro Pimentel-Nunes; Joana Magalhães; Ricardo Magalhães; Nuno Veloso; Carlos Ferreira; Pedro Figueiredo; Pedro Moutinho; Mário Dinis-Ribeiro
Journal:  Gastrointest Endosc       Date:  2013-11-26       Impact factor: 9.427

8.  Gastric high-risk gist and retroperitoneal liposarcoma--a challenging combination of two mesenchymal tumor lesions with regard to diagnosis and treatment.

Authors:  Jőrg Arend; Doerthe Kuester; Albert Roessner; Hans Lippert; Frank Meyer
Journal:  Pol Przegl Chir       Date:  2013-05

9.  Diagnosis of gastric intraepithelial neoplasia by narrow-band imaging and confocal laser endomicroscopy.

Authors:  Shu-Fang Wang; Yun-Sheng Yang; Li-Xin Wei; Zhong-Sheng Lu; Ming-Zhou Guo; Jin Huang; Li-Hua Peng; Gang Sun; En-Qiang Ling-Hu; Jiang-Yun Meng
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

10.  Cytologic diagnosis of gastric submucosal lesions by endoscopic ultrasound-guided fine-needle aspiration: A single center experience in Saudi Arabia.

Authors:  Emad Raddaoui; Majid A Almadi; Abdulrahman M Aljebreen; Faisal Alsaif
Journal:  Indian J Pathol Microbiol       Date:  2015 Oct-Dec       Impact factor: 0.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.